Shattuck Labs
Bo joined Shattuck in April 2019 as Senior Director of Biometrics. She has over 14 years of oncology clinical development experience spanning from early to late phase in both pharmaceutical and biotechnology companies. Bo has comprehensive experience in oncology early phase clinical development and has been the statistical lead for several oncology compounds. Prior to joining Shattuck, Bo was the Senior Director of Biostatistics in early phase oncology clinical program at Medimmune/AstraZeneca. Bo started her career as a Clinical Trial Statistician at GlaxoSmithKline (GSK) and spent eight years in oncology clinical development at GSK. After leaving GSK, Bo spent about three years in a biotech company as the Director of Statistics. Bo received her PhD in Biostatistics from the University of South Carolina.
This person is not in any offices
Shattuck Labs
Shattuck is a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease.